Naveen Kumar Amar joins the surgical robot developer as it prepares to expand globally, including in Europe and the U.S.

The device, called Biolinq Shine, is indicated for people with Type 2 diabetes who don’t depend on insulin. Biolinq says its ...

The request includes a call to postpone re-certification requirements for devices already certified under the medical ...

The Trump administration has used the investigations in other sectors to implement tariffs, but the earliest any potential ...

Dallara, president of Medtronic’s diabetes business, discussed the segment’s turnaround and why she sees a benefit in ...

Guardant Health and Quest Diagnostics will collaborate to offer Guardant’s Shield blood-based colorectal cancer test through ...

Heartflow disclosed the clearance alongside news that Cigna has become the second national insurer after UnitedHealthcare to ...

Cardiosense’s switch to a leader with experience scaling healthtech companies comes as it works to build on the recent 510(k) ...

Johnson & Johnson, which said it made the decision based on a market assessment, did not specify the markets it is leaving or ...

From cardiac ablation devices to OTC glucose sensors, explore how breakthrough medical technologies are disrupting ...

The Medtronic center will facilitate surgeon collaboration and AI-powered decision support. At Virtuoso Surgical, a robotic ...

Heart surgeon Sudhir Srivastava saw a global need for less-invasive surgical care at an affordable price. His company, SS ...